STOCK TITAN
  1. Home
  2. Sec-filings
  3. FRST
  4. [8-K] Primis Financial Corp. Reports Material Event

Primis Financial director to exit, board shrinks to 10

Primis Financial Corp. (FRST) reported a board change.

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Primis Financial Corp. (FRST) reported a board change. On August 28, 2026, Dr. Allen R. Jones, Jr. notified the boards of Primis Financial Corp. and Primis Bank of his intention to resign as a director, effective August 31, 2026. The company states that Dr. Jones’ resignation was not the result of any dispute or disagreement regarding its operations, policies, or practices.

Dr. Jones also served on the Enterprise Risk Committee and will resign from that committee. Following his resignation, the size of the company’s Board of Directors will be reduced from eleven to ten directors.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Effective resignation date August 31, 2026 Date Dr. Allen R. Jones, Jr.’s resignation as director becomes effective
Board size before resignation 11 directors Size of Primis Financial Corp. Board of Directors prior to Dr. Jones’ resignation
Board size after resignation 10 directors Size of Primis Financial Corp. Board of Directors effective upon Dr. Jones’ resignation
Notification date August 28, 2026 Date Dr. Jones notified the boards of his intention to resign
Enterprise Risk Committee financial
"At the time of his resignation, Dr. Jones was a member of the Enterprise Risk Committee"
Emerging growth company regulatory
"405) or Rule 12b-2 of the Securities Exchange Act of 1934 ... Emerging growth company"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Section 12(b) of the Act regulatory
"Securities registered pursuant to Section 12(b) of the Act"

FAQ

What board change did Primis Financial Corp. (FRST) announce on August 28, 2026?
Primis Financial Corp. disclosed that director Dr. Allen R. Jones, Jr. notified the boards on August 28, 2026 of his intention to resign as a director of both Primis Financial Corp. and Primis Bank, effective August 31, 2026.

Why is director Dr. Allen R. Jones, Jr. resigning from Primis Financial Corp. (FRST)?
Primis Financial Corp. states that Dr. Jones’ resignation was not the result of any dispute or disagreement with the company or its board on matters relating to operations, policies, or practices.

When does the resignation of Dr. Allen R. Jones, Jr. from FRST become effective?
The resignation of Dr. Allen R. Jones, Jr. from the boards of Primis Financial Corp. and Primis Bank becomes effective on August 31, 2026.

How will the board size of Primis Financial Corp. (FRST) change after the resignation?
Effective upon Dr. Jones’ resignation on August 31, 2026, the size of Primis Financial Corp.’s Board of Directors will be reduced from eleven directors to ten directors.

What committee role did Dr. Allen R. Jones, Jr. hold at Primis Financial Corp. (FRST)?
Dr. Allen R. Jones, Jr. was a member of the Enterprise Risk Committee. Upon his resignation as a director, he will also be resigning from this committee.

Does the 8-K report any disagreement between FRST and Dr. Allen R. Jones, Jr.?
No. Primis Financial Corp. states that Dr. Jones’ resignation was not due to any dispute or disagreement with the company or its Board of Directors regarding operations, policies, or practices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001325670 0001325670 2026-08-28 2026-08-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

 

Form 8-K

 

 

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): August 28, 2026

 

PRIMIS FINANCIAL CORP.

(Exact name of registrant as specified in its charter)

 

Virginia 001-33037 20-1417448
(State or other jurisdiction of
incorporation)		 (Commission File Number) (IRS Employer Identification
No.)

 

1676 International Drive, Suite 900
McLean, Virginia 22102

(Address of Principal Executive Offices) (Zip Code)

 

(703) 893-7400

(Registrant's telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchanged on which registered
COMMON STOCK   FRST   NASDAQ

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On August 28, 2026, Dr. Allen R. Jones, Jr. notified the Board of Directors of Primis Financial Corp. and Primis Bank (collectively, the “Company”) of his intention to resign as a director of the Company, effective as of August 31, 2026. Dr. Jones’ resignation was not the result of any dispute or disagreement with the Company or the Company’s Board of Directors on any matter relating to the operations, policies or practices of the Company. At the time of his resignation, Dr. Jones was a member of the Enterprise Risk Committee and as a result, will also be resigning as a member of the Enterprise Risk Committee. Effective upon Dr. Jones’ resignation as a director, the size of the Company’s Board of Directors will be reduced from eleven to ten directors.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PRIMIS FINANCIAL CORP.
     
August 31, 2026 By:  /s/ Matthew A. Switzer
  Matthew A. Switzer
  Chief Financial Officer

 

 

 

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents